TY - JOUR AU - Nair, Harish AU - Verma, Vasundhara R. AU - Theodoratou, Evropi AU - Zgaga, Lina AU - Huda, Tanvir AU - Simões, Eric AF AU - Wright, Peter F. AU - Rudan, Igor AU - Campbell, Harry PY - 2011 DA - 2011/04/13 TI - An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children JO - BMC Public Health SP - S30 VL - 11 IS - 3 AB - Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children. It is estimated to cause approximately 33.8 million new episodes of ALRI in children annually, 96% of these occurring in developing countries. It is also estimated to result in about 53,000 to 199,000 deaths annually in young children. Currently there are several vaccine and immunoprophylaxis candidates against RSV in the developmental phase targeting active and passive immunization. SN - 1471-2458 UR - https://doi.org/10.1186/1471-2458-11-S3-S30 DO - 10.1186/1471-2458-11-S3-S30 ID - Nair2011 ER -